XML 123 R104.htm IDEA: XBRL DOCUMENT v3.8.0.1
PARENT COMPANY ONLY FINANCIAL STATEMENTS - CONDENSED STATEMENTS OF CASH FLOWS (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 08, 2016
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net income (loss)   $ 34,136 $ (972) $ 15,439
Adjustments to reconcile net income to net cash provided by operating activities:        
Accretion of loan discounts, net   (4,755) (8,358) (4,806)
Amortization of issuance costs of subordinated notes   145 9 0
Provision for loan losses   14,360 64,700 17,864
Deferred income tax expense (benefit)   5,243 8,361 (3,409)
Increase in other assets, net   12,775 (16,520) 2,208
Increase in other liabilities, net   3,658 1,838 (1,379)
Net cash provided (used in) by operating activities   89,034 73,434 26,904
CASH FLOWS FROM INVESTING ACTIVITIES:        
Net increase in loans held for investment and held for sale   (154,951) (115,148) (279,756)
Net cash (used by) provided by investing activities   (537,964) (48,602) (119,225)
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from issuance of subordinated notes, net $ 33,900 0 33,876 0
Common stock issued in connection with the exercise of stock options   486 3,046 1,534
Purchase of treasury stock   0 (1,253) 0
Net cash provided by financing activities   200,604 239,269 148,304
NET INCREASE IN CASH AND CASH EQUIVALENTS   (248,326) 264,101 55,983
CASH AND CASH EQUIVALENTS:        
Beginning of year   389,007 124,906 68,923
End of year   140,681 389,007 124,906
Green Bancorp, Inc.        
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net income (loss)   34,136 (972) 15,439
Adjustments to reconcile net income to net cash provided by operating activities:        
Equity in undistributed earnings of subsidiary   (44,427) (1,577) (17,995)
Accretion of loan discounts, net   (7) 0 0
Amortization of debt valuation allowance   420 420 105
Amortization of issuance costs of subordinated notes   145 9 0
Provision for loan losses   10,536 0 0
Net loss on loans held-for-sale   138 0 0
Proceeds from sales of held-for-sale loans   12,560 0 0
Deferred income tax expense (benefit)   (1,074) (130) (18)
Increase in other assets, net   (6,148) (41) (295)
Increase in other liabilities, net   68 114 146
Net cash provided (used in) by operating activities   6,347 (2,177) (2,618)
CASH FLOWS FROM INVESTING ACTIVITIES:        
Purchase of loans from subsidiary   0 (32,819) 0
Capital contributed to subsidiary   (12,000) 0 0
Net increase in loans held for investment and held for sale   (4,886) 0 0
Net cash and cash equivalents paid in connection with acquisitions   0 0 2,740
Net cash (used by) provided by investing activities   (16,886) (32,819) 2,740
CASH FLOWS FROM FINANCING ACTIVITIES:        
Proceeds from issuance of subordinated notes, net   0 33,876 0
Common stock issued in connection with the exercise of stock options   486 3,046 1,534
Purchase of treasury stock   0 (1,253) 0
Net cash provided by financing activities   486 35,669 1,534
NET INCREASE IN CASH AND CASH EQUIVALENTS   (10,053) 673 1,656
CASH AND CASH EQUIVALENTS:        
Beginning of year   10,995 10,322 8,666
End of year   $ 942 $ 10,995 $ 10,322